Literature DB >> 23409252

Complete genome sequence of a highly virulent newcastle disease virus currently circulating in Mexico.

Sa Xiao1, Anandan Paldurai, Baibaswata Nayak, Armando Mirande, Peter L Collins, Siba K Samal.   

Abstract

The complete genome sequence was determined for a highly virulent Newcastle disease virus strain from vaccinated chicken farms in Mexico during outbreaks in 2010. On the basis of phylogenetic analysis this strain was classified into genotype V in the class II cluster that was closely related to Mexican strains that appeared in 2004-2006.

Entities:  

Year:  2013        PMID: 23409252      PMCID: PMC3569268          DOI: 10.1128/genomeA.00177-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Newcastle disease (ND) is a highly contagious viral disease in avian species and causes large economic losses in the poultry industry. Newcastle disease virus (NDV) is a member of the genus Avulavirus in the family Paramyxoviridae. The genome of NDV is a single-stranded, negative-sense, nonsegmented RNA with six genes encoding seven major viral proteins (1). NDV strains are divided into two classes based on genetic analysis: class I strains have been isolated mainly from wild birds and are generally avirulent, whereas class II strains have been recovered from wild and domestic birds and include virulent and avirulent isolates (2). Class I and II viruses are divided into 9 and 11 genotypes, respectively (3). Currently circulating strains in chickens around the world are genotypes V, VI, and VII of class II. Although all commercial chickens are routinely vaccinated with live NDV vaccine B1 or LaSota, ND continues to be a major problem for the poultry industry (4). In North America, Mexico is the only country where highly virulent NDV strains are circulating (4). In 2010, NDV outbreaks affected chicken farms located in the states of Coahuila and Durango in North Central Mexico, in an agricultural region known as La Laguna in Mexico. ND outbreaks occurred in commercial vaccinated chickens, causing up to 24% to 36% mortality. Tissue samples, including tissue from lungs, trachea, spleen, and cecal tonsils, were taken from dead and sick broilers exhibiting central nervous system (CNS) signs and severe dyspnea. One of the isolates, namely, Mexico/01/10, was purified, and the genome sequence was determined by reverse transcription (RT)-PCR using overlapped consensus primers and direct sequencing. The 3′ and 5′ termini were determined by rapid amplification of cDNA ends (RACE) (5). The complete genome of Mexico/01/10 is 15,192 nucleotides in length. The amino acid sequence identities of fusion (F) and hemagglutinin-neuraminidase (HN) proteins between Mexico/01/10 and Mexican strains isolated in 2004–2006 are 99% and 98%, respectively (6, 7). However, the amino acid sequence identity of the F and HN proteins between Mexico/01/10 and the currently used vaccine strain LaSota is 89%. This indicates that the circulating strains are substantially distinct from the vaccine strain in use and suggests that antigenic differences contributed to poor vaccine protection. The sequence of the F protein cleavage site is a major determinant of NDV pathogenicity. The cleavage sites of virulent NDV strains usually contain multiple basic residues, whereas avirulent strains have fewer basic residues (8, 9). The Mexican isolate has a virulent pathotype: RRQKR↓F (underlining represents the basic residue; arrow represents the site of cleavage). Phylogenetic analysis of the complete coding region of the F gene constructed by MEGA4.0 indicated that it was within genotype V in class II and is more closely related to Mexico isolates that appeared in 2004–2006, demonstrating that the highly virulent NDV strains are still circulating in Mexico with minor genetic variations.

Nucleotide sequence accession number.

The complete genome sequence of Mexico/01/10 has been deposited in GenBank under the accession number JX974435.
  7 in total

1.  Complete genome sequence of a velogenic Newcastle disease virus isolated in Mexico.

Authors:  Angel E Absalón; Andrea Mariano-Matías; Alejandra Vásquez-Márquez; Andrés Morales-Garzón; Diana V Cortés-Espinosa; Roberto Ortega-García; Eduardo Lucio-Decanini
Journal:  Virus Genes       Date:  2012-07-21       Impact factor: 2.332

2.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications.

Authors:  Alíz Czeglédi; Dorina Ujvári; Eszter Somogyi; Eniko Wehmann; Ortrud Werner; Béla Lomniczi
Journal:  Virus Res       Date:  2006-09       Impact factor: 3.303

4.  Biological and phylogenetic characterization of virulent Newcastle disease virus circulating in Mexico.

Authors:  F Perozo; R Merino; C L Afonso; P Villegas; N Calderon
Journal:  Avian Dis       Date:  2008-09       Impact factor: 1.577

Review 5.  Newcastle disease: evolution of genotypes and the related diagnostic challenges.

Authors:  Patti J Miller; Eduardo Lucio Decanini; Claudio L Afonso
Journal:  Infect Genet Evol       Date:  2009-09-30       Impact factor: 3.342

6.  Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses.

Authors:  Sa Xiao; Anandan Paldurai; Baibaswata Nayak; Madhuri Subbiah; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

7.  Role of fusion protein cleavage site in the virulence of Newcastle disease virus.

Authors:  Aruna Panda; Zhuhui Huang; Subbiah Elankumaran; Daniel D Rockemann; Siba K Samal
Journal:  Microb Pathog       Date:  2004-01       Impact factor: 3.738

  7 in total
  5 in total

1.  Separate evolution of virulent newcastle disease viruses from Mexico and Central America.

Authors:  Leonardo Susta; Krishna R Hamal; Patti J Miller; Stivalis Cardenas-Garcia; Corrie C Brown; Janice C Pedersen; Victor Gongora; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

2.  Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.

Authors:  Shin-Hee Kim; Zongyan Chen; Asuka Yoshida; Anandan Paldurai; Sa Xiao; Siba K Samal
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

3.  Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan.

Authors:  Muhammad Hidayat Rasool; Asif Mehmood; Muhammad Saqalein; Muhammad Atif Nisar; Ahmad Almatroudi; Mohsin Khurshid
Journal:  Biomed Res Int       Date:  2021-01-29       Impact factor: 3.411

4.  The 3D8 single chain variable fragment protein suppresses Newcastle disease virus transmission in transgenic chickens.

Authors:  Sung June Byun; Hoonsung Choi; Shanmugam Sureshkumar; Seong-Su Yuk; Jung-Hoon Kwon; Jin-Yong Noh; Sun Keun Jung; Jeom Sun Kim; Keon Bong Oh; Hyeon Yang; Gunsup Lee; Hwi-Cheul Lee; Jae-Seok Woo; Chang-Seon Song
Journal:  BMC Vet Res       Date:  2020-08-06       Impact factor: 2.741

5.  Analysis of bioactive composites and antiviral activity of Iresine herbstii extracts against Newcastle disease virus in ovo.

Authors:  Rahat Andleeb; Asma Ashraf; Saima Muzammil; Shabana Naz; Farkhanda Asad; Tayyaba Ali; Rida Rafi; K A Al-Ghanim; F Al-Misned; Z Ahmed; Shahid Mahboob
Journal:  Saudi J Biol Sci       Date:  2019-10-11       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.